Original news and analysis on international IP policy
As part of a series of publications on investment treaties and investor-state dispute settlement, a developing country multilateral organisation released a policy brief focusing on Ecuador's experience and action against the current dispute settlement system.
The final draft of India’s national intellectual property policy has been circulated for inter-ministerial consultation and will be sent to the Cabinet for approval after receiving comments, the Ministry of Commerce and Industry said this week. Meanwhile, today public health groups in India announced that revocation of a Roche pharmaceutical patent has been upheld under Indian law.
Despite progress in recent years to boost local pharmaceutical production in developing countries, policy coherence across the countries is lacking, according to an official at the United Nations Conference on Trade and Development (UNCTAD).
The Russian government is crafting a new strategy in the field of intellectual property, which should strengthen the protection of IP rights in Russia and create conditions for the acceleration of the domestic research activities in the country, according to Dmitry Livanov of Russia’s Ministry of Science and Education.
Much will depend on Australian federal judges after a website blocking bill targeting copyright violations was passed by both houses of the Australian legislature this week.
The Trans-Pacific Partnership (TPP), part of US President Barack Obama’s promised pivot to Asia, has stirred up a hornet’s nest on the ethics of trying to hammer out a trade deal in secrecy. But it is not the only one. A proposed trade agreement in Asia, the Regional Comprehensive Economic Partnership (RCEP), is facing the same hiccups and flak.
From the New York Times: WASHINGTON — Facing resistance from its Pacific trading partners, the Obama administration is no longer demanding protection for pharmaceutical prices under the 12-nation Trans-Pacific Partnership, according to a newly leaked “transparency” annex of the proposed trade accord.
But American negotiators are still pressing participating governments to open up the process that sets reimbursement rates for drugs and medical devices. Public health professionals, generic drugmakers and activists opposed to the trade deal, which is still being negotiated, contend that it will empower big pharmaceutical firms to command higher reimbursement rates in the United States and abroad, at the expense of consumers.
MUNICH -- The agreement of the heads of states of the United States, Canada, Japan, United Kingdom, France, Italy and Germany to reduce global warning to less than two degrees made the biggest headlines of the G7 Summit on Elmau Castle, Germany, in the Bavarian Alps. Also agreed were commitments on trade and on public health, including research and development for neglected diseases.
While a full range of stakeholders would be affected by the outcome of the Trans-Pacific Partnership (TPP) agreement under secret negotiation by the United States and a dozen trading partners, corporate representatives have had a special seat at the negotiating table, as shown by hundreds of pages of confidential emails from the US Trade Representative’s office obtained by Intellectual Property Watch. The emails give a rare and fascinating perspective on how policy is developed in the trade office.
Patent activity is currently at an all-time high, with statistics showing large growth across industry sectors in the volume of patents being filed. However, the production of scientific literature is declining, according to a new report from Thomson Reuters.
Intellectual property rights are among the issues given detailed analysis in the latest trade policy review of India by the World Trade Organization under review this week. Turns out, India has been quite busy on IP rights over the past few years.
Although most people in the world live within reach of a mobile internet signal, a considerable amount of mobile users in developing countries are not using the opportunity to go online. One of the factors, according to a panel today, is the lack of locally relevant content.